The founding ceremony of Haoyuan API’s industrialization base was held in Cihu High-Tech Zone, Ma’anshan, Anhui Province

Number of visits:1653 Date:2018-05-23

      On May 23, 2018, the groundbreaking ceremony for the API of Haoyuan was held in Cihu High-Tech Zone, Ma’anshan, Anhui Province. Present at the ceremony were Yuefeng Zhang(Party Secretary of the Municipal Committee), Shanwu Zhou(Member of the Standing Committee of the Municipal Party Committee, and Deputy Mayor of the Municipal Party Committee),Guilin Wu( Member of the Standing Committee of the Municipal Party Committee, Secretary of the Municipal Party Committee, and Secretary of the Political-legal Committee), Langping (Party Secretary of the Party Committee, Director of the Management Committee), Yali Zhang (Deputy Secretary of the Party Committee, Director Deputy Director) and others.

     The new API factory project was built by Anhui Haoyuan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Shanghai Haoyuan Chemexpress Co., Ltd. When the project completed, 11 APIs and intermediates will be produced in large scale, which involve vitamin D drugs, antitumor drugs , anticoagulant drugs and other fields. The new API factory will further strengthen the world’s leading pharmaceutical research and development and production services.

      At present, Haoyuan owns an international leading technology team, with first-class R&D innovation and market development capabilities. It produces high-quality products to dock with international well-konwed original pharmaceutical factories. Haoyuan had set up sales centers in Hong Kong, the United States, and Europe. The sales network is spread over 27 countries and provinces and cities. After the completion of the project, it is planned to apply for the national standard certification of from the United States (FDA), Europe (EDQM), Japan, etc.. Haoyuan will work hard to build an industry-leading new technology platform from the laboratory to the commercial scale, and provide partners with APIs’ integration services from R&D to production from pre-clinical to commercialized. 

      The new API factory project marked a key step in project construction. Anhui Haoyuan Pharmaceutical Co., Ltd. will adhere to the development strategy of “Taking the human health industry as the main business, taking pharmaceutical research and development as the core”. With the spirit of ingenuity, we will build the company into a pharmaceutical enterprise that meets international standards. In the future, Haoyuan will become the world's firs-rate API manufacture.

Back to top